|Day Low/High||0.13 / 0.14|
|52 Wk Low/High||0.07 / 0.29|
As planned, Director Stephen Keen to resign to lead Sterling Pharms, which is set to test Surna equipment; provide efficiency and efficacy testing; and act as tour and validation facility
Keating brings more than 31 years of Wall Street and capital markets experience
Proceeds to be used for sales expansion and strategic growth
Before Bernie Sanders got hip to the whole pot thing, the marijuana industry had a different presidential contender BFF: Rand Paul.
Want to invest in marijuana stocks? You'd better do your homework first -- otherwise, you might get burned.
Cogent Communications falls after its third-quarter results miss expectations.
Cramer would want to get out the stock, but he's sticking by Dresser-Rand.
From BEA Systems to Serena, the reports to watch in this sector will be generated by one group.
The corporate struggle to meet new regulations is a boon to some software firms.
Richard Suttmeier's valuation model held up well under the strain of last week's tech earnings.
When second-tier stocks report, assessing their prospects can be tricky.
The stock is set to rise after the company reports earnings of 24 cents a share before items.
Century Small-Cap Select's Thorndike explains how his process has proven a winner.
Enjoy the rally, but get ready to sell short again. Also, consider these three shorts.
Farley gets knee-deep into reader Q&A: continuation moves, a Fibonacci tutorial, TICKs and more...
Analysts like what they see and say they're optimistic about the company's prospects.